Icon

JYLAMVO (NDA212479)- (2MG/ML,2MG/ML,2MG/ML)

METHOTREXATE SHORLA
2MG/ML,2MG/ML,2MG/ML
No Yes
2035-Oct-28 Expired
None None
None No
JYLAMVO is a folate analog metabolic inhibitor indicated for the: • Treatment of adults with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen • Treatment of adults with mycosis fungoides • Treatment of adults with relapsed or refractory non-Hodgkin lymphoma as part of a metronomic combination regimen • Treatment of adults with rheumatoid arthritis • Treatment of adults with severe psoriasis
0 0 0
Total Other Developers None
Drugs with Suitability No
2MG/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.